Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients.
Oncotarget
Montes, Paola P; Kerick, Martin M; Bernal, Mónica M; Hernández, Francisca F; Jiménez, Pilar P; Garrido, Pilar P; Márquez, Ana A; Jurado, Manuel M; Martin, Javier J; Garrido, Federico F; Ruiz-Cabello, Francisco F
Publication Date: 2018-12-11
Variant appearance in text: TET2: 3635T>A; Leu1212*